1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals, Inc. XNAS: REGN

Regeneron Pharma Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet ag...

Read More
746.82 20.61 (2.84%)
56.73% Gain from 52W Low
916.4K
XNAS Volume

XNAS 11 Dec, 2025 3:59 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
42.7 / 100
Momentum Score
Technically Moderately Bullish
61.9 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
781
1Yr Price target upside is 5%
26 analysts

24

S

5

W

2

O

2

T

SWOT Analysis

Regeneron Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..